Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Summary

RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well everolimus works in treating women with breast cancer that can be removed by surgery.

Timeline

Start

2008-07

Primary completion

2009-06

Completion

2009-06

Outcome

Outcome not reported

Stopped (Enrollment): “Withdrawn due to no accrual”

Drugs

Indications